These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38131520)

  • 1. A comparative transcranial magnetic stimulation study: Assessing cortical excitability and plasticity in Alzheimer's disease, dementia with Lewy bodies and Frontotemporal dementia.
    Olğun Y; Aksoy Poyraz C; Bozluolçay M; Gündüz A; Poyraz BÇ
    Psychogeriatrics; 2024 Mar; 24(2):272-280. PubMed ID: 38131520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
    Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
    Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
    Chaudhry A; Houlden H; Rizig M
    J Neurol Sci; 2020 Aug; 415():116886. PubMed ID: 32428759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies.
    Binnewijzend MA; Kuijer JP; van der Flier WM; Benedictus MR; Möller CM; Pijnenburg YA; Lemstra AW; Prins ND; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Eur Radiol; 2014 Sep; 24(9):2326-33. PubMed ID: 24996793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.
    Longobardi A; Catania M; Geviti A; Salvi E; Vecchi ER; Bellini S; Saraceno C; Nicsanu R; Squitti R; Binetti G; Di Fede G; Ghidoni R
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
    Herbert MK; Aerts MB; Kuiperij HB; Claassen JAHR; Spies PE; Esselink RAJ; Bloem BR; Verbeek MM
    Alzheimers Dement; 2014 Jul; 10(4):448-455.e2. PubMed ID: 24239248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Measurements of Motor Function in Alzheimer's Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies: A Proof-of-Concept Study.
    Jeppesen Kragh F; Bruun M; Budtz-Jørgensen E; Hjermind LE; Schubert R; Reilmann R; Nielsen JE; Hasselbalch SG
    Dement Geriatr Cogn Disord; 2018; 46(3-4):168-179. PubMed ID: 30257254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor cortical excitability and paired-associative stimulation-induced plasticity in amnestic mild cognitive impairment and Alzheimer's disease.
    Meder A; Liepelt-Scarfone I; Sulzer P; Berg D; Laske C; Preische O; Desideri D; Zipser CM; Salvadore G; Tatikola K; Timmers M; Ziemann U
    Clin Neurophysiol; 2021 Sep; 132(9):2264-2273. PubMed ID: 33612394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of QOL between patients with different degenerative dementias, focusing especially on positive and negative affect.
    Kurisu K; Terada S; Oshima E; Horiuchi M; Imai N; Yabe M; Yokota O; Ishihara T; Yamada N
    Int Psychogeriatr; 2016 Aug; 28(8):1355-61. PubMed ID: 27020694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy.
    Padovani A; Benussi A; Cotelli MS; Ferrari C; Cantoni V; Dell'Era V; Turrone R; Paghera B; Borroni B
    Alzheimers Res Ther; 2019 Dec; 11(1):95. PubMed ID: 31787103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.
    Spies PE; Slats D; Sjögren JM; Kremer BP; Verhey FR; Rikkert MG; Verbeek MM
    Curr Alzheimer Res; 2010 Aug; 7(5):470-6. PubMed ID: 20043812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.
    Beagle AJ; Darwish SM; Ranasinghe KG; La AL; Karageorgiou E; Vossel KA
    J Alzheimers Dis; 2017; 60(1):211-223. PubMed ID: 28826176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features.
    Garn H; Coronel C; Waser M; Caravias G; Ransmayr G
    J Neural Transm (Vienna); 2017 May; 124(5):569-581. PubMed ID: 28243755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.
    Spehl TS; Frings L; Hellwig S; Weiller C; Hüll M; Meyer PT; Amtage F
    Clin Nucl Med; 2015 Jan; 40(1):e27-33. PubMed ID: 25140560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration.
    Duignan JA; Haughey A; Kinsella JA; Killeen RP
    Semin Nucl Med; 2021 May; 51(3):264-274. PubMed ID: 33402272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset.
    Di Lorenzo F; Ponzo V; Bonnì S; Motta C; Negrão Serra PC; Bozzali M; Caltagirone C; Martorana A; Koch G
    Ann Neurol; 2016 Aug; 80(2):202-10. PubMed ID: 27255833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Cerebellar Theta Burst Stimulation on Contralateral Motor Cortex Excitability in Patients with Alzheimer's Disease.
    Di Lorenzo F; Bonnì S; Picazio S; Motta C; Caltagirone C; Martorana A; Koch G
    Brain Topogr; 2020 Sep; 33(5):613-617. PubMed ID: 32564167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.